On behalf of the Arcas Group team, we wish you an enjoyable and relaxing holiday season!
In preparation for a prosperous 2012, please accept our gift of complimentary MDOUTLOOK® Analysis Reports.
MDOUTLOOK, our exclusive web-based platform, provides the marketplace insight critical to reaching your commercialization goals. Our customized approach engages over 60,000 multi-disciplinary specialists active in oncology care worldwide.
Complimentary 2011 Analysis Reports – immediately available for download:
* Global Clinical Impact of Bevacizumab Revocation in metastatic Breast Cancer
* Recent Developments in the Treatment of Myelofibrosis
* New Clinical Data in Pancreatic Neuroendocrine Tumors
* ASCO 2011: Immediate Impact on Clinical Practice in NSCLC
* ASCO 2011: Immediate Impact on Clinical Practice in Melanoma
* ASCO 2011: Immediate Impact on Clinical Practice in Gastrointestinal Cancer
Explore MDOutlook to discover the advantage of total oncology intelligence. You can preview the MDOUTLOOK advantage here or contact us at firstname.lastname@example.org to discuss your intelligence needs.
With best wishes for 2012!
The Arcas Group and MDOUTLOOK Teams